These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7028049)

  • 1. [Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)].
    Torres J; Savopoulos C; Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1373-6. PubMed ID: 7028049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-European open clinical studies on the efficacy and tolerance of ciclopiroxolamine in dermatomycoses (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1381-5. PubMed ID: 7028052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
    Adam W; Peil HG; Savopoulos C; Vanderbeke O
    Arzneimittelforschung; 1981; 31(8A):1360-5. PubMed ID: 7028047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
    Fredriksson T; Savopoulos C
    Arzneimittelforschung; 1981; 31(8A):1376-8. PubMed ID: 7028050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream].
    Beyer M
    Arzneimittelforschung; 1981; 31(8A):1378-81. PubMed ID: 7028051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
    Peil HG
    Arzneimittelforschung; 1981; 31(8A):1366-8. PubMed ID: 7028048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)].
    Qadripur SA; Horn G; Höhler T
    Arzneimittelforschung; 1981; 31(8A):1369-72. PubMed ID: 6457608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological laboratory studies with ciclopiroxolamine (author's transl)].
    Dittmar W; Grau W; Raether W; Schrinner E; Wagner WH
    Arzneimittelforschung; 1981; 31(8A):1317-22. PubMed ID: 7197538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].
    Petri W
    Arzneimittelforschung; 1981; 31(8A):1332-7. PubMed ID: 7197540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An open clinico-mycologic study on the efficiency and tolerability of ciclopiroxolamine].
    Lasagni A; Oriani A; Terragni L
    G Ital Dermatol Venereol; 1986; 121(2):XXIX-XXXII. PubMed ID: 3710527
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
    Jue SG; Dawson GW; Brogden RN
    Drugs; 1985 Apr; 29(4):330-41. PubMed ID: 3158508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the pharmacology and toxicology of ciclopiroxolamine (author's transl)].
    Alpermann HG; Schütz E
    Arzneimittelforschung; 1981; 31(8A):1328-32. PubMed ID: 7197539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ciclopiroxolamine in the topical treatment of vaginal mycoses].
    Bucciero A; Molteni E; Molteni B; Mariani W; Jacobellis M
    Minerva Ginecol; 1989 Jun; 41(6):283-6. PubMed ID: 2771141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Penetration and antifungal activity of ciclopiroxolamine in hornified tissue (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1353-9. PubMed ID: 7197542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)].
    Iwata K; Yamaguchi H
    Arzneimittelforschung; 1981; 31(8A):1323-7. PubMed ID: 7028046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre clinical study with tolciclate in the local treatment of skin mycoses in 1083 patients.
    Intini C; Battaglia A; Mangiarotti AM; Picco AM; Viaro D; Sacchetti G
    Pharmatherapeutica; 1980; 2(7):439-49. PubMed ID: 7010381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of dermatomycoses with ciclopiroxolamine].
    Szepes E; Schneider I
    Mykosen; 1986 Aug; 29(8):382-6. PubMed ID: 3762592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor].
    Corte M; Jung K; Linker U; Martini H; Sapp-Boncelet I; Schulz H
    Mycoses; 1989 Apr; 32(4):200-3. PubMed ID: 2755466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of bifonazole and ciclopiroxolamine: in vitro, animal, and clinical studies.
    Hänel H; Abrams B; Dittmar W; Ehlers G
    Mycoses; 1988 Dec; 31(12):632-40. PubMed ID: 3068545
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter evaluation of the activity and tolerance of a new antimycotic agent: ciclopiroxolamine].
    Cattaneo M; Betti R; Lodi A; Masnada MC
    G Ital Dermatol Venereol; 1986; 121(6):LXXXI-LXXXV. PubMed ID: 3557531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.